OAM
Ostrum Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Sell |
6,111
-175
| -3% | -$22K | 0.04% | 348 |
|
|
2025
Q1 | $695K | Sell |
6,286
-4,917
| -44% | -$544K | 0.04% | 362 |
|
|
2024
Q4 | $1.53M | Sell |
11,203
-8,439
| -43% | -$1.15M | 0.13% | 242 |
|
|
2024
Q3 | $2.26M | Buy |
19,642
+239
| +1% | +$27.5K | 0.19% | 196 |
|
|
2024
Q2 | $2.67M | Sell |
19,403
-1,508
| -7% | -$208K | 0.23% | 141 |
|
|
2024
Q1 | $2.88M | Hold |
20,911
| – | – | 0.23% | 136 |
|
|
2023
Q4 | $2.76M | Sell |
20,911
-8,225
| -28% | -$1.08M | 0.24% | 135 |
|
|
2023
Q3 | $3.28M | Buy |
29,136
+3,028
| +12% | +$341K | 0.3% | 81 |
|
|
2023
Q2 | $2.46M | Buy |
26,108
+23
| +0.1% | +$2.17K | 0.21% | 164 |
|
|
2023
Q1 | $2.64M | Buy |
+26,085
| New | +$2.64M | 0.23% | 149 |
|